Skip to main content
Toggle navigation
Login
Search
Home
Preview Program
Poster Schedule
Home
Poster Schedule
All Days
Fri, Apr 24
Sat, Apr 25
Poster Schedule
Type here to filter the list
Saturday, April 25, 2026
9:45 AM - 1:30 PM
PT
(95) Behavioral Addictions Might Be More Common and Harmful Than Previously Thought
Favorite
9:45 AM - 1:30 PM
PT
(96) Mothers in Addiction Treatment: Demographic and Clinical Trends from 2005 to 2025
Favorite
9:45 AM - 1:30 PM
PT
(97) Lift Me Up or Bring Me Down: Partner Influence on Substance Use
Favorite
9:45 AM - 1:30 PM
PT
(98) Substance Use Disorders and Fertility Care: Disparities in Evaluation and Treatment
Favorite
9:45 AM - 1:30 PM
PT
(99) Comparing Postpartum MOUD Monitoring Across Integrated vs Separate Prenatal Care Models
Favorite
9:45 AM - 1:30 PM
PT
(100) EHR Affects Stigma Manifestations and Care Decisions by Peripartum Women With SUD
Favorite
9:45 AM - 1:30 PM
PT
(101) Does Neighborhood Disadvantage Affect Pregnant Patients With Opioid Use Disorder?
Favorite
9:45 AM - 1:30 PM
PT
(102) Start High, Go Fast: Rapid Split-Dose Inpatient Methadone Titration in Pregnancy
Favorite
9:45 AM - 1:30 PM
PT
(103) Treatment Recommendations for Benzodiazepine Use in Pregnancy: A Scoping Review
Favorite
9:45 AM - 1:30 PM
PT
(104) Child Custody Loss and Prenatal Engagement in Pregnant Women With Substance Use
Favorite
9:45 AM - 1:30 PM
PT
(105) Revised Drug Screening Restores Equity Without Compromising Neonatal Safety
Favorite
9:45 AM - 1:30 PM
PT
(106) The Promise of Extended-Release Buprenorphine for Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(107) Inadequate Pharmacy Stocking of Buprenorphine in Washington, DC: A Cross-Sectional Survey
Favorite
9:45 AM - 1:30 PM
PT
(108) Associations Between Remission from Opioid Use Disorder and Treatment-Relevant Outcomes
Favorite
9:45 AM - 1:30 PM
PT
(109) Injectable OUD Medications via Telehealth Providers and Local Pharmacies
Favorite
9:45 AM - 1:30 PM
PT
(110) The Effect of Music on Opioid-Related Cue Reactivity
Favorite
9:45 AM - 1:30 PM
PT
(111) GLP-1 Receptor Agonists Improve Outcomes in Patients Receiving Buprenorphine for OUD
Favorite
9:45 AM - 1:30 PM
PT
(112) Buy-In Without a Blueprint: ED Buprenorphine Initiation in Puerto Rico
Favorite
9:45 AM - 1:30 PM
PT
(113) Addiction Medicine Consultation for Patients at Post-Acute Long-Term Care Facilities
Favorite
9:45 AM - 1:30 PM
PT
(114) Early Uptake and Utilization Patterns of Long-Acting Injectable Buprenorphine
Favorite
9:45 AM - 1:30 PM
PT
(115) Higher Buprenorphine Doses Improve Treatment Engagement and Outcomes in Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(116) Patient Outcomes After Field-Initiated Buprenorphine With and Without ED Transport
Favorite
9:45 AM - 1:30 PM
PT
(117) Implementing Harm Reduction in a Binational Context: Key Informant Perspectives
Favorite
9:45 AM - 1:30 PM
PT
(118) Opioid-Stimulant Injecting and Smoking: Multilevel Influences in San Diego-Tijuana
Favorite
9:45 AM - 1:30 PM
PT
(119) Closing the Gap: Inpatient Methadone and Telehealth OTP Enrollment
Favorite
9:45 AM - 1:30 PM
PT
(120) Modeling the Effects of Global Opioid Treatment Recommendations on US Methadone and Buprenorphine Access
Favorite
9:45 AM - 1:30 PM
PT
(121) Expanding Access: Empowering Recovery Through Self-Administered Methadone
Favorite
9:45 AM - 1:30 PM
PT
(122) Social Isolation and Loneliness Among Older Adults With Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(123) Barriers to Inpatient Use of Opioid-Agonist Therapies
Favorite
9:45 AM - 1:30 PM
PT
(124) Rising Regional Burden of Substance Use Disorders: GBD 2023 Analysis
Favorite
9:45 AM - 1:30 PM
PT
(125) Feasibility of Addiction CaRE: A Program Supporting Hospitalized Patients With SUD
Favorite
9:45 AM - 1:30 PM
PT
(126) Care Barriers & Health Complaints: People Who Inject Drugs in San Antonio
Favorite
9:45 AM - 1:30 PM
PT
(127) Characterizing Quality of Life for People Who Use Drugs
Favorite
9:45 AM - 1:30 PM
PT
(128) Perspectives from People Who Use Drugs: Experiences Using Fentanyl Containing BTMPS
Favorite
9:45 AM - 1:30 PM
PT
(129) Recurrent Overdose Survival Modeling for Smarter Harm Reduction Deployment
Favorite
9:45 AM - 1:30 PM
PT
(130) Recovery Housing Without Abstinence Requirements: Outcomes of a Low-Threshold Pilot
Favorite
9:45 AM - 1:30 PM
PT
(131) Increased Social Support May Provide a Protective Effect Against Recurrent Drug Overdoses
Favorite
9:45 AM - 1:30 PM
PT
(132) Drivers and Deterrents of Accessing Care for Patients With Xylazine-Associated Wounds
Favorite
9:45 AM - 1:30 PM
PT
(133) Rural-Urban Disparities in Tobacco, Alcohol, and Opioid Co-Use Among US Adults, 2021–2023
Favorite
9:45 AM - 1:30 PM
PT
(134) Mapping Non-Fatal Overdoses in Palm Beach County: Spatial Risk Analysis
Favorite
9:45 AM - 1:30 PM
PT
(135) Auditing Documentation Language in OUD Admissions Using Privacy-Preserving Local LLMs
Favorite
9:45 AM - 1:30 PM
PT
(136) Opioid Treatment Engagement and Retention: A Risk and Protective Factor Examination
Favorite
9:45 AM - 1:30 PM
PT
(137) Concurrent Mental Illness in a Fentanyl Cohort: Treatment Gaps and Overdose/Suicide Risks
Favorite
9:45 AM - 1:30 PM
PT
(138) The Impact of Substance Use on Mental Health Care in Adolescents
Favorite
9:45 AM - 1:30 PM
PT
(139) Investigating Mediators Between Antecedent Childhood Trauma and Drug Overdose Among Adults
Favorite
9:45 AM - 1:30 PM
PT
(140) Mapping Psychosocial Pathways From Trauma to Substance Use Risk in Immigrant Adolescents
Favorite
9:45 AM - 1:30 PM
PT
(141) Patient-Provider Relationship Quality in Teens at Risk for Substance Use
Favorite
9:45 AM - 1:30 PM
PT
(142) Naltrexone Treatment for AI Chatbot Addiction in Adolescent With ASD and ADHD
Favorite
9:45 AM - 1:30 PM
PT
(143) Meta-Analysis of Ketamine’s Effects on Craving and Abstinence in Substance Use Disorders
Favorite
9:45 AM - 1:30 PM
PT
(144) Towards Accurate Interpretations of Liver Transplantation Outcomes in Alcohol Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(145) Alcohol Screening During Surgical Hospitalization Expands Opportunity for Addiction Care
Favorite
9:45 AM - 1:30 PM
PT
(146) Provider-Reported Barriers to Screening and Treating Alcohol Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(147) Hepatic Failure as an Obstacle in Treating Alcohol Withdrawal and Serotonin Toxicity
Favorite
9:45 AM - 1:30 PM
PT
(148) Tacrolimus Variability With Cannabis Use After Alcohol-Associated Liver Transplant
Favorite
9:45 AM - 1:30 PM
PT
(149) Safety of Naltrexone for Alcohol Use Disorder Treatment in Liver Transplant Recipients
Favorite
9:45 AM - 1:30 PM
PT
(150) Consequences of GLP-1 Coverage Loss in Alcohol Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(151) Interactions of Gender Identity and Social Factors in Unhealthy Alcohol Use
Favorite
9:45 AM - 1:30 PM
PT
(152) Socioeconomic Status and Unhealthy Alcohol Use Among Transgender Adults
Favorite
9:45 AM - 1:30 PM
PT
(153) Hospital Alcohol Withdrawal Protocol: Improving Outcomes and Reducing Length of Stay
Favorite
9:45 AM - 1:30 PM
PT
(154) When Treatment Turns Toxic: Naltrexone-Induced Psychosis During Alcohol Withdrawal
Favorite
9:45 AM - 1:30 PM
PT
(155) One Measure, Two Stories: How AUDIT vs. AUDIT-C Shape SBIRT Implementation
Favorite
9:45 AM - 1:30 PM
PT
(156) Designing a Contingency Management App to Support Opioid Agonist Therapy
Favorite
9:45 AM - 1:30 PM
PT
(157) Examining National Harm Reduction and Impact on Implementation of Contingency Management
Favorite
9:45 AM - 1:30 PM
PT
(158) Distinct Depression-Craving Trajectories During Naltrexone Treatment for Cocaine Use
Favorite
9:45 AM - 1:30 PM
PT
(159) College Shouldn't be a Relapse Risk: National Evidence on Collegiate Recovery
Favorite
9:45 AM - 1:30 PM
PT
(160) Motivation for Change and Treatment Among Transition-Age Adults With Substance Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(161) Treating Substance Use Disorder in Interim Housing Settings With Contingency Management
Favorite
9:45 AM - 1:30 PM
PT
(162) Adult Cannabis Usage Pattern in a Rural Ohio Community
Favorite
9:45 AM - 1:30 PM
PT
(163) Naloxone Training Improves Medical Students’ Knowledge and Attitudes: A Two-Year Survey
Favorite
9:45 AM - 1:30 PM
PT
(164) Educational Attainment Levels Shape Substance Use, Disorder Risk, and Care Access
Favorite
9:45 AM - 1:30 PM
PT
(165) Provider Education and Patient Screening for In-Hospital Substance Use: A QI Project
Favorite
9:45 AM - 1:30 PM
PT
(166) Reddit Discussions About Stimulant Use and ADHD Symptoms
Favorite
9:45 AM - 1:30 PM
PT
(167) Creative Arts Groups Promote Connection and Flourishing in SUD Recovery
Favorite
9:45 AM - 1:30 PM
PT
(168) Impact of Resource Linkage on Rehospitalization in People With Substance Use Disorders
Favorite
9:45 AM - 1:30 PM
PT
(169) Live One, Do One, Teach One: Building Recovery Support Services Workforce Capacity
Favorite
9:45 AM - 1:30 PM
PT
(170) From Crisis to Connection: Insights From the THRIVE Peer Recovery Program
Favorite
9:45 AM - 1:30 PM
PT
(171) Bridging Care: Patient Navigation and Support Team Within an Addiction Consult Service
Favorite
9:45 AM - 1:30 PM
PT
(172) Paths to Recovery: An Integrated, Rapid-Access Model for Outpatient Addiction Care
Favorite
9:45 AM - 1:30 PM
PT
(173) Patients With Opioid Use Disorder Report Compassionate Care but Missed Support Opportunity
Favorite
9:45 AM - 1:30 PM
PT
(174) Intensive Community Care Reduces Over-Utilization of Healthcare Resources
Favorite
9:45 AM - 1:30 PM
PT
(175) Provider Perspectives and Understanding of Urine Drug Screening
Favorite
9:45 AM - 1:30 PM
PT
(176) Accuracy of Urine Drug Screen for Substances Other Than Opioids in Pregnancy
Favorite
9:45 AM - 1:30 PM
PT
(177) Predictors of Engagement in a Remote Tobacco Cessation Randomized Trial
Favorite
9:45 AM - 1:30 PM
PT
(178) Predictors of Success in an Intensive, Online Smoking Cessation Program (MINDonline)
Favorite
9:45 AM - 1:30 PM
PT
(179) Outcomes for Patients With Substance Use History Evaluated for Advanced Cardiac Therapies
Favorite
9:45 AM - 1:30 PM
PT
(180) No Colon Left Behind: Increasing Colorectal Cancer Screening Rates Among SUD Patients
Favorite
9:45 AM - 1:30 PM
PT
(181) Inpatient Order Set Increases Initiation of Medications for Substance Use Disorders
Favorite
9:45 AM - 1:30 PM
PT
(182) Evidence for Safety and Tolerability of Transcranial Magnetic Stimulation for SUD
Favorite
9:45 AM - 1:30 PM
PT
(183) Nitrous Oxide Induced Myelopathy With Acute Urinary Retention and Pulmonary Embolism
Favorite
9:45 AM - 1:30 PM
PT
(184) BRAIN GAS: B12 Reduction and Ataxia From Inhaled Nitrous Oxide
Favorite
9:45 AM - 1:30 PM
PT
(185) Trends in Documentation of Stigmatizing Language for Addiction from 2013 to Present
Favorite
9:45 AM - 1:30 PM
PT
(186) Words Do Hurt: Curbing Stigmatizing Words in Substance Use Disorder Treatment
Favorite
9:45 AM - 1:30 PM
PT
(187) Access to Urban Setting AA Meetings Reflects Income, Race, and Educational Disparities
Favorite
